News
04-21-2010, 01:11 AM
Silence Therapeutics plc announces that the Company and AstraZeneca have agreed to a one-year extension of their ongoing small interfering RNA (siRNA) delivery collaboration. Under this collaboration, which was originally entered into in March 2008, the companies are leveraging a number of Silence's proprietary lipid delivery and targeting technologies to develop new and enhanced delivery approaches for RNA interference (RNAi) therapeutics.
More... (http://www.news-medical.net/news/20100421/Silence-Therapeutics-AstraZeneca-announce-one-year-extension-of-ongoing-siRNA-delivery-collaboration.aspx)
More... (http://www.news-medical.net/news/20100421/Silence-Therapeutics-AstraZeneca-announce-one-year-extension-of-ongoing-siRNA-delivery-collaboration.aspx)